Crisis of Confidence: Novartis Faces Investor Backlash Following String of Clinical Setbacks
Novartis, the Swiss pharmaceutical titan, is currently grappling with more than just the $30 billion evaporation of its market capitalization...
Novartis, the Swiss pharmaceutical titan, is currently grappling with more than just the $30 billion evaporation of its market capitalization...